SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CORALLINI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.121
AS - Asia 1.550
EU - Europa 807
SA - Sud America 223
AF - Africa 25
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.733
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.064
SG - Singapore 636
CN - Cina 540
BR - Brasile 199
UA - Ucraina 188
DE - Germania 157
GB - Regno Unito 129
HK - Hong Kong 125
IT - Italia 125
TR - Turchia 118
FI - Finlandia 57
VN - Vietnam 56
SE - Svezia 39
CA - Canada 38
RU - Federazione Russa 32
PL - Polonia 20
FR - Francia 17
IN - India 17
ZA - Sudafrica 17
AR - Argentina 14
MX - Messico 14
CZ - Repubblica Ceca 10
ES - Italia 8
BD - Bangladesh 7
ID - Indonesia 7
IQ - Iraq 7
LT - Lituania 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
BE - Belgio 5
IR - Iran 5
JP - Giappone 5
NL - Olanda 5
CO - Colombia 3
IL - Israele 3
NP - Nepal 3
PK - Pakistan 3
UZ - Uzbekistan 3
EC - Ecuador 2
EG - Egitto 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 6.733
Salva come PNG Salva come JPEG
Città #
Fairfield 505
Woodbridge 470
Ashburn 380
Singapore 307
Houston 267
Seattle 223
Ann Arbor 221
Chandler 211
Jacksonville 209
Cambridge 183
Wilmington 166
Beijing 159
Santa Clara 150
Hong Kong 125
Dallas 77
New York 77
Los Angeles 76
Nanjing 69
Izmir 66
Princeton 47
Munich 36
San Diego 35
Boardman 34
Milan 31
Shanghai 26
Shenyang 25
Nanchang 23
Ho Chi Minh City 22
São Paulo 22
Ferrara 21
Buffalo 20
Warsaw 16
Tianjin 15
Changsha 14
Falls Church 13
Jinan 13
Montreal 13
San Mateo 13
Hanoi 12
Johannesburg 12
The Dalles 12
Turku 12
Auburn Hills 11
Hebei 11
London 11
Mountain View 11
Zhengzhou 11
Chicago 10
Frankfurt am Main 10
Mexico City 10
San Francisco 10
Chennai 9
Dearborn 9
Hefei 9
Poplar 9
Falkenstein 8
Stockholm 8
Bremen 7
Brno 7
Orem 7
Philadelphia 7
Toronto 7
Atlanta 6
Boston 6
Brasília 6
Brooklyn 6
Columbus 6
Haikou 6
Moscow 6
Ottawa 6
Redwood City 6
Rome 6
Brussels 5
Charlotte 5
Denver 5
Kunming 5
Norwalk 5
Porto Alegre 5
Tappahannock 5
Tokyo 5
Ardabil 4
Curitiba 4
Guarulhos 4
Hangzhou 4
Leawood 4
Manchester 4
Phoenix 4
Rio de Janeiro 4
Vancouver 4
Ankara 3
Augusta 3
Bologna 3
Changchun 3
Des Moines 3
Guangzhou 3
Helsinki 3
Jakarta 3
Jiaxing 3
Padova 3
Paris 3
Totale 4.779
Salva come PNG Salva come JPEG
Nome #
Antiangiogenic activity of the MDM2 antagonist nutlin-3 215
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 206
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 203
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 203
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies 192
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 192
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 186
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 185
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 183
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 180
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 178
Is there any role for tumour necrosis factor related apoptosis inducing ligand–osteoprotegerin (TRAIL–OPG) interaction in rheumatoid arthritis? 175
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 172
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 167
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 166
Potential role of PKC inhibitors in the treatment of hematological malignancies 162
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 160
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 155
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 149
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 148
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 148
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 146
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 144
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 142
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 142
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 133
TRAIL, caspases and maturation of normal and leukemic myeloid precursors 132
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 127
Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction 119
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 119
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis 118
An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction 114
null 102
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 101
null 97
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand 96
null 94
TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL 90
null 90
null 89
null 88
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 87
null 86
Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 83
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 81
null 78
null 74
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 71
null 65
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 57
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 45
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL) 35
Totale 6.770
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021333 0 0 0 0 0 56 15 73 16 68 75 30
2021/2022522 15 57 56 11 15 26 35 25 14 29 66 173
2022/2023457 40 23 17 49 80 78 25 40 47 7 28 23
2023/2024197 16 26 3 5 11 51 9 13 1 3 3 56
2024/2025988 21 32 66 50 144 72 23 47 216 75 143 99
2025/20261.448 281 99 287 344 394 43 0 0 0 0 0 0
Totale 6.770